Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000083·Coya Therapeutics, Inc.
Schedule 13G ownership disclosure
Coya Therapeutics Inc
Common Stock · CUSIP: 22407B108
Event date: 2025-12-31
- Filing-level shares
- 899,140
- Percent of class
- 4.29%
- The Vanguard Group
Shares: 899,140 · Class: 4.29%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000083
- Form type
- SCHEDULE 13G/A
- Filer
- Coya Therapeutics, Inc.
- CIK
- CIK 1835022
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership